Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hydrocephalus in neuromyelitis optica.
Clardy SL, Lucchinetti CF, Krecke KN, Lennon VA, O'Toole O, Weinshenker BG, Boyd CD, Krieger S, McGraw C, Guo Y, Pittock SJ. Clardy SL, et al. Among authors: mcgraw c. Neurology. 2014 May 20;82(20):1841-3. doi: 10.1212/WNL.0000000000000428. Epub 2014 Apr 23. Neurology. 2014. PMID: 24759842 Free PMC article.
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.
Vidaurre OG, Haines JD, Katz Sand I, Adula KP, Huynh JL, McGraw CA, Zhang F, Varghese M, Sotirchos E, Bhargava P, Bandaru VV, Pasinetti G, Zhang W, Inglese M, Calabresi PA, Wu G, Miller AE, Haughey NJ, Lublin FD, Casaccia P. Vidaurre OG, et al. Brain. 2014 Aug;137(Pt 8):2271-86. doi: 10.1093/brain/awu139. Epub 2014 Jun 3. Brain. 2014. PMID: 24893707 Free PMC article.
Interferon beta and glatiramer acetate therapy.
McGraw CA, Lublin FD. McGraw CA, et al. Neurotherapeutics. 2013 Jan;10(1):2-18. doi: 10.1007/s13311-012-0163-4. Neurotherapeutics. 2013. PMID: 23264098 Free PMC article. Review.
Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: An interim analysis.
Jimenez AD, Gopaul M, Asbell H, Aydemir S, Basha MM, Batra A, Damien C, Day GS, Eka O, Eschbach K, Fatima S, Fields MC, Foreman B, Gerard EE, Gofton TE, Haider HA, Hantus ST, Hocker S, Jongeling A, Kalkach Aparicio M, Kandula P, Kang P, Kazazian K, Kellogg MA, Kim M, Lee JW, Marcuse LV, McGraw CM, Mohamed W, Orozco J, Pimentel C, Punia V, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Treister AK, Yoo JY, Zafar S, Zhou DJ, Zutshi D, Gaspard N, Hirsch LJ, Hanin A. Jimenez AD, et al. Among authors: mcgraw cm. Epilepsia. 2024 Apr 16. doi: 10.1111/epi.17988. Online ahead of print. Epilepsia. 2024. PMID: 38625055
Patient-reported outcomes based on discontinuation or continuous treatment with natalizumab: New York State Multiple Sclerosis Consortium (NYSMSC) study.
Jakimovski D, Kavak KS, Zakalik K, McGraw C, Gottesman M, Coyle PK, Zivadinov R, Weinstock-Guttman B; New York State Multiple Sclerosis Consortium (NYSMSC). Jakimovski D, et al. Among authors: mcgraw c. J Neurol Sci. 2023 Dec 15;455:122781. doi: 10.1016/j.jns.2023.122781. Epub 2023 Nov 14. J Neurol Sci. 2023. PMID: 37979415
153 results